Drug or treatment
Eptinezumab clinical trials
As of November 12, 2026, Find a Trial lists 6 clinical trials of Eptinezumab that are recruiting, at sites in 11 countries (most in Italy (5), Canada (4), Argentina (3)). By phase: Phase 3 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 11Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Early Eptinezumab for Acute Post-Traumatic Headache | Phase 3 | Toronto, Ontario | Recruiting | Sep 24, 2025 |
| Eptinezumab given during a migraine attack (BE-FREE) | — | Roma | Recruiting | Oct 8, 2024 |
| Eptinezumab for treating episodic migraine in children | Phase 3 | Stamford, Connecticut and 59 other locations | Recruiting | Jun 9, 2023 |
| Assessing the effectiveness of eptinezumab for migraine treatment in real-world settings | — | Roma, RM | Recruiting | Oct 6, 2022 |
| Long-term safety of eptinezumab for children and adolescents with migraines | Phase 3 | New Haven, Connecticut and 63 other locations | Recruiting | Dec 20, 2021 |
| Eptinezumab treatment for adolescents with chronic migraine | Phase 3 | New Haven, Connecticut and 78 other locations | Recruiting | Jul 16, 2021 |
All recruiting trials (6)
-
Early Eptinezumab for Acute Post-Traumatic Headache
This study tests whether a single infusion of eptinezumab can help people with acute post-traumatic headaches, particularly those with a migraine-like pattern, after a mild brain injury.
-
Eptinezumab given during a migraine attack (BE-FREE)
This will test whether an IV dose of eptinezumab can stop an ongoing migraine attack in people who have at least eight migraine days per month.
-
Eptinezumab for treating episodic migraine in children
This study tests if a new medication called eptinezumab can help reduce the number of migraine days in children who have episodic migraines.
-
Assessing the effectiveness of eptinezumab for migraine treatment in real-world settings
This study is testing how well eptinezumab, an IV treatment for migraines, works in real life for people who have frequent migraines and haven't had success with other treatments.
-
Long-term safety of eptinezumab for children and adolescents with migraines
This study is testing the long-term safety of a migraine medication called eptinezumab in children and teens aged 6 to 17 who have chronic or episodic migraines.
-
Eptinezumab treatment for adolescents with chronic migraine
This study is testing if a single infusion of eptinezumab can help reduce the number of migraine days for adolescents aged 12 to 17 who suffer from chronic migraines.
Quick answers
How many clinical trials of Eptinezumab are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in Italy (5 trials), Canada (4 trials), Argentina (3 trials), Mexico (3 trials), Poland (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.